Detection of benign granular cell tumor of the breast via 18F-PSMA-PET/CT in a patient with very high-risk prostate cancer: A case report

被引:0
|
作者
Ghabili, Kamyar [1 ]
Rajyaguru, Rushi [1 ]
De La Plante, Alexandra [2 ]
Widders, Kristine L. [3 ]
Chetlen, Alison L. [1 ]
Choe, Angela I. [1 ]
Kasales, Claudia J. [1 ]
机构
[1] Penn State Hlth Milton S Hershey Med Ctr, Dept Radiol, Hershey, PA USA
[2] Penn State Hlth Milton S Hershey Med Ctr, Dept Pathol, Hershey, PA USA
[3] Penn State Hlth Milton S Hershey Med Ctr, Dept Surg, Hershey, PA USA
来源
SAGE OPEN MEDICAL CASE REPORTS | 2024年 / 12卷
关键词
Breast; granular cell tumor; positron emission tomography; prostate cancer; prostate-specific membrane antigen;
D O I
10.1177/2050313X241275826
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Incidental extra-prostatic prostate-specific membrane antigen (PSMA) uptake on initial staging positron emission tomography/computed tomography (PET/CT) scans poses diagnostic challenges, as it can be associated with various benign and malignant lesions. We present the case of a 68-year-old man with very high-risk prostate cancer who was incidentally discovered to have a benign granular cell tumor in the breast initially detected on PSMA-PET/CT. Imaging studies and biopsy were pivotal in the diagnosis, as the tumor's appearance was concerning for breast carcinoma. Recognizing extra-prostatic PSMA uptake in the breast, particularly in patients with prostate cancer, is crucial for guiding appropriate management, accurately interpreting subsequent imaging findings, and assessing radiologic-pathologic correlation.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Impact of 18F-PSMA-11 PET/CT on Management of Biochemical Recurrence and High-Risk Prostate Cancer Staging 18F-PSMA-11 PET/CT and Impact on Prostate Cancer Management
    De Man, Kathia
    Piron, Sarah
    Van Laeken, Nick
    Delrue, Louke
    Fonteyne, Valerie
    Lumen, Nicolaas
    Van den Broeck, Bliede
    Kersemans, Ken
    Ost, Piet
    Schelfhout, Vanessa
    MOLECULAR IMAGING AND BIOLOGY, 2022, 24 (05) : 750 - 758
  • [2] Impact of 18F-PSMA-11 PET/CT on Management of Biochemical Recurrence and High-Risk Prostate Cancer Staging18F-PSMA-11 PET/CT and Impact on Prostate Cancer Management
    Kathia De Man
    Sarah Piron
    Nick Van Laeken
    Louke Delrue
    Valérie Fonteyne
    Nicolaas Lumen
    Bliede Van den Broeck
    Ken Kersemans
    Piet Ost
    Vanessa Schelfhout
    Molecular Imaging and Biology, 2022, 24 : 750 - 758
  • [3] A prospective, multicenter head-to-head comparative study in patients with primary high-risk prostate cancer investigating the bone lesion detection of conventional imaging and 18F-PSMA-PET/CT
    Bodar, Y. J. L.
    Luining, W. I.
    Keizer, B.
    Meijer, D.
    Schaaf, M.
    Vellekoop, A.
    Hendrikse, N. H.
    Van Moorselaar, R. J. A.
    Oprea-Lager, D. E.
    Vis, A. N.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (04) : 205.e17 - 205.e24
  • [4] The value of 18F-PSMA-1007 PET/CT in identifying non-metastatic high-risk prostate cancer
    Jun-jie Hong
    Bo-le Liu
    Zhi-qiang Wang
    Kun Tang
    Xiao-wei Ji
    Wei-wei Yin
    Jie Lin
    Xiang-wu Zheng
    EJNMMI Research, 10
  • [5] The value of 18F-PSMA-1007 PET/CT in identifying non-metastatic high-risk prostate cancer
    Hong, Jun-jie
    Liu, Bo-le
    Wang, Zhi-qiang
    Tang, Kun
    Ji, Xiao-wei
    Yin, Wei-wei
    Lin, Jie
    Zheng, Xiang-wu
    EJNMMI RESEARCH, 2020, 10 (01)
  • [6] Comparison of 18F-PSMA-1007 PET/CT With 68Ga-PSMA-11 PET/CT for Initial Staging in Intermediate- and High-Risk Prostate Cancer
    Chandekar, Kunal Ramesh
    Singh, Harmandeep
    Kumar, Rajender
    Kumar, Santosh
    Kakkar, Nandita
    Mittal, Bhagwant Rai
    Singh, Shrawan Kumar
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (01) : E1 - E8
  • [7] Detection of Synchronous Primary Breast and Prostate Cancer by F-18 Fluorocholine PET/CT
    Kwee, Sandi A.
    Coel, Marc N.
    CLINICAL NUCLEAR MEDICINE, 2010, 35 (02) : 128 - 129
  • [8] 68Ga-PSMA PET/CT and PET/MRI in high-risk prostate cancer patients
    Sanli, Yasemin
    Sanli, Oner
    Simsek, Duygu Has
    Subramaniam, Rathan M.
    NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (10) : 871 - 880
  • [9] Prospective Evaluation of 18F-DCFPyL PET/CT in Detection of High-Risk Localized Prostate Cancer: Comparison With mpMRI
    Gaur, Sonia
    Mena, Esther
    Harmon, Stephanie A.
    Lindenberg, Maria L.
    Adler, Stephen
    Ton, Anita T.
    Shih, Joanna H.
    Mehralivand, Sherif
    Merino, Maria J.
    Wood, Bradford J.
    Pinto, Peter A.
    Mease, Ronnie C.
    Pomper, Martin G.
    Choyke, Peter L.
    Turkbey, Baris
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2020, 215 (03) : 652 - 659
  • [10] The Diagnostic Role of 18F-Choline, 18F-Fluciclovine and 18F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta-Analysis
    Wang, Rang
    Shen, Guohua
    Huang, Mingxing
    Tian, Rong
    FRONTIERS IN ONCOLOGY, 2021, 11